A Conversation With the Myeloma Experts: Making Sense of the Evolving Treatment Landscape

Get up to date on the latest strategies for managing newly diagnosed and relapsed/refractory multiple myeloma (R/R MM) with downloadable slides an on-demand webcast a downloadable clinical resource and an expert commentary from a satellite symposium at ASH 2022.

Share

Program Content

Activities

Treatment Landscape in Myeloma
Making Sense of the Evolving Treatment Landscape for Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2023

Expires: February 29, 2024

View Activity

Activities

Managing Smoldering Myeloma
Smoldering Myeloma: Determining Risk of Progression and Considerations for Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
Newly Diagnosed MM: Therapy
Considerations for Front-Line Therapy: Selecting Optimal Therapy for Newly Diagnosed MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
R/R MM: After Multiple Relapses
Considerations for Relapsed/Refractory MM After Multiple Lines of Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
Therapy with R/R MM after BCMA-Targeted Tx
Considerations for Therapy Selection in Patients with R/R MM After BCMA-Targeted Treatment: Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2022

Expires: December 08, 2023

View Activity
2023 MM Care Algorithm
Introduction to the 2023 MM Care Algorithm
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2022

Expires: December 11, 2023

View Activity
Tx for MM At First Relapse
Considerations for Treatment of Multiple Myeloma At First Relapse
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2022

Expires: December 28, 2023

View Activity

Activities

Myeloma Conversations
A Conversation With the Myeloma Experts: Making Sense of the Evolving Treatment Landscape
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 24, 2023

Expires: January 23, 2024

View Activity

Faculty

cover img faculity

Brian G. M. Durie, MD

National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.
Co-Chair, Myeloma Committee – SWOG
Chairman, International Myeloma Foundation
Specialist, Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Yi Lin

Professor of Medicine, Division of Hematology
Division of Experimental Pathology
Chair, Cell Therapy Cross-Disciplinary Group
Mayo Clinic Comprehensive Cancer Center
Associate Medical Director, Mayo Clinic Center for Regenerative Biotherapeutics
Mayo Clinic
Rochester, Minnesota

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

cover img faculity

S. Vincent Rajkumar, MD

Edward W. and Betty Knight Scripps–Edward C. Rosenow, III, MD
Professor of Medicine
Associate Editor, Mayo Clinic Proceedings
Mayo Clinic
Rochester, Minnesota

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc.

Takeda Pharm USA

Partners

International Myeloma Foundation

ProCE Banner